Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Hinge Health Q3 2026 Results: Turns Profitable, Net Income $57.4M

Hinge Health, Inc. filed its Form 10-Q for the quarter ended September 30, 2026, reporting a dual-class common stock structure with 68,485,043 Class A and 12,786,259 Class B shares outstanding. The company highlights its expansion into Migraine and Gastrointestinal care programs and the acquisition of Cylinder Health, Inc., while cautioning that it has a history of net losses and may not achieve profitability.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue235.0154.2
Gross profit204.3126.2
Profit before tax53.7-1.6
Net income57.4-1.8
EPS (diluted, $ a share)$0.66$-0.02

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Revenue, year on year+52.4%
Gross margin87.0%
Operating margin21.4%
Source

10-Q filed with the SEC, NYSE: HNGE. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Hinge Health, Inc.: key numbers

Share price
$121.29Close, Nov 16
Sector
Technology
Industry
Services-Computer Processing & Data PreparationSIC 7374

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Hinge Health, Inc.

All →
6:30 PM ET Form 4
Insider Selling

Hinge Health Director Gabriel M.i. Mecklenburg Sells $24.5M of Stock

Gabriel M.i. Mecklenburg, Director, sold 200,000 shares of Hinge Health, Inc. at $121.76 to $125.50 a share (average $122.41) in 5 transactions, worth $24.5M in total on Nov 11, 2026. Shares held after the trade: 0 (-100.0%).

Value
$24.5M
Shares
200,000
Average price
$122.41
Role
Director
Holding change
-100.0%
Trade date
Nov 11, 2026
6:29 PM ET Form 4
Insider Selling

Hinge Health CFO James Budge Sells $4.37M of Stock

James Budge, CFO, sold 35,907 shares of Hinge Health, Inc. at $119.52 to $123.34 a share (average $121.62) in 5 transactions, worth $4.37M in total on Nov 10, 2026. Shares held after the trade: 256,207 (-2.1%).

Value
$4.37M
Shares
35,907
Average price
$121.62
Role
CFO
Holding change
-2.1%
Trade date
Nov 10, 2026
4:07 PM ET 8-K
Financial Results

Hinge Health Financial Results

Hinge Health reported record Q3 2026 results with revenue growing 52% year-over-year to $235 million and a significant increase in non-GAAP operating margin to 33%. The company raised its full-year 2026 revenue guidance to approximately $880 million and announced that President James Pursley will transition to a role on the Board of Directors in January 2027.

Term
Q3 2026

“Our strong performance continues to reflect our ability to deliver exceptional clinical outcomes, a better healthcare experience and lower client costs at scale. This focus on the triple aim, via a technology platform that scales and automates care delivery, is also resulting in a record sales season.”

Daniel Perez, Co-Founder and CEO

“We wouldn't be the company we are today if not for Jim. He's been instrumental in our scaling to over 3,200 clients. I'm grateful for all he's done and that he'll continue contributing to our success as a board member and advisor.”

Daniel Perez, Co-Founder and CEO
5:28 PM ET Form 4
Insider Selling

Hinge Health CFO James Budge Sells $4.92M of Stock

James Budge, CFO, sold 47,720 shares of Hinge Health, Inc. at $101.53 to $104.33 a share (average $103.13) in 4 transactions, worth $4.92M in total on Oct 12, 2026. Shares held after the trade: 296,728 (-3.1%).

Value
$4.92M
Shares
47,720
Average price
$103.13
Role
CFO
Holding change
-3.1%
Trade date
Oct 12, 2026
5:27 PM ET Form 4
Insider Selling

Hinge Health Director Gabriel M.i. Mecklenburg Sells $20.6M of Stock

Gabriel M.i. Mecklenburg, Director, sold 200,000 shares of Hinge Health, Inc. at $101.53 to $104.34 a share (average $103.13) in 4 transactions, worth $20.6M in total on Oct 12, 2026. Shares held after the trade: 0 (-100.0%).

Value
$20.6M
Shares
200,000
Average price
$103.13
Role
Director
Holding change
-100.0%
Trade date
Oct 12, 2026
9:58 PM ET Form 4
Insider Selling

Hinge Health CEO & Co-Founder Daniel Antonio Perez Sells $411K of Stock

Daniel Antonio Perez, CEO & Co-Founder, sold 4,100 shares of Hinge Health, Inc. at $100.20 a share, worth $411K in total on Oct 6, 2026. Shares held after the trade: 0 (-100.0%).

Value
$411K
Shares
4,100
Price
$100.20
Role
CEO & Co-Founder
Holding change
-100.0%
Trade date
Oct 6, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.